Rapid Hybridoma Screening Method for the Identification of Monoclonal Antibodies to Low-Abundance Cytoplasmic Proteins
Screening assays are the most time-consuming and labor-intensive part of generating monoclonal antibodies (MAbs). Antibodies identified by enzyme-linked immunosorbent assay (ELISA) screening often are not suitable for their intended application such as immunofluorescence staining. We describe here a...
Saved in:
| Main Authors: | L.A. O’Reilly, L. Cullen, K. Moriishi, L. O’Connor, D.C.S. Huang, A. Strasser |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
1998-11-01
|
| Series: | BioTechniques |
| Online Access: | https://www.future-science.com/doi/10.2144/98255st03 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications
by: Samantha Zaroff, et al.
Published: (2019-09-01) -
Targeted fusion of antibody-secreting cells: Unlocking monoclonal antibody production with hybridoma technology
by: Fanny Rousseau, et al.
Published: (2025-12-01) -
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies to Shiga-Like Toxins of I and II Types
by: G. V. Kuklina, et al.
Published: (2021-10-01) -
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies against Coronavirus SARS-CоV-2
by: G. V. Kuklina, et al.
Published: (2023-05-01) -
Protocol for culture, purification, and target validation of a hybridoma-generated monoclonal antibody targeting Aβ truncated species
by: Maria Luisa Valle, et al.
Published: (2025-06-01)